FI953887A0 - Farmaceutiska kefaklorkompositioner - Google Patents

Farmaceutiska kefaklorkompositioner

Info

Publication number
FI953887A0
FI953887A0 FI953887A FI953887A FI953887A0 FI 953887 A0 FI953887 A0 FI 953887A0 FI 953887 A FI953887 A FI 953887A FI 953887 A FI953887 A FI 953887A FI 953887 A0 FI953887 A0 FI 953887A0
Authority
FI
Finland
Prior art keywords
cefaclor
pharmaceutical
cephachlor
compositions
manufacture
Prior art date
Application number
FI953887A
Other languages
English (en)
Finnish (fi)
Other versions
FI953887A (sv
Inventor
Flavia Arce Mendizabal
Original Assignee
Lilly Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Sa filed Critical Lilly Sa
Publication of FI953887A0 publication Critical patent/FI953887A0/sv
Publication of FI953887A publication Critical patent/FI953887A/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
FI953887A 1994-12-13 1995-08-17 Farmaceutiska kefaklorkompositioner FI953887A (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09402530A ES2079327B1 (es) 1994-12-13 1994-12-13 Formulaciones farmaceuticas de cefaclor.

Publications (2)

Publication Number Publication Date
FI953887A0 true FI953887A0 (sv) 1995-08-17
FI953887A FI953887A (sv) 1996-06-14

Family

ID=8288235

Family Applications (1)

Application Number Title Priority Date Filing Date
FI953887A FI953887A (sv) 1994-12-13 1995-08-17 Farmaceutiska kefaklorkompositioner

Country Status (32)

Country Link
US (1) US5861141A (sv)
EP (3) EP1086690A3 (sv)
JP (1) JPH08208484A (sv)
KR (1) KR100350565B1 (sv)
CN (1) CN1136852C (sv)
AT (1) ATE201984T1 (sv)
AU (1) AU702585B2 (sv)
BR (1) BR9504573A (sv)
CA (1) CA2158511A1 (sv)
CO (1) CO4410176A1 (sv)
CZ (1) CZ287248B6 (sv)
DE (2) DE716852T1 (sv)
DK (1) DK0716852T3 (sv)
ES (2) ES2079327B1 (sv)
FI (1) FI953887A (sv)
GR (2) GR960300062T1 (sv)
HK (1) HK1012574A1 (sv)
HU (1) HUT73792A (sv)
IL (1) IL114642A (sv)
MY (1) MY114687A (sv)
NO (1) NO309925B1 (sv)
NZ (1) NZ272611A (sv)
PE (1) PE5196A1 (sv)
PL (1) PL181437B1 (sv)
PT (1) PT716852E (sv)
RU (1) RU2150276C1 (sv)
SI (1) SI0716852T1 (sv)
TR (1) TR199501165A1 (sv)
TW (1) TW492875B (sv)
UA (1) UA34479C2 (sv)
YU (1) YU60795A (sv)
ZA (1) ZA956411B (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0890359T3 (da) * 1996-02-29 2002-07-01 Fujisawa Pharmaceutical Co Beta-Lactam-antibiotikumholdige tabletter og fremgangsmåde til fremstilling deraf
WO1999018965A1 (en) * 1997-10-10 1999-04-22 Yamanouchi Europe B.V. Oral compositions containing a cephalosporin antibiotic
ES2257886T3 (es) * 1998-12-01 2006-08-01 Dr. Reddy's Research Foundation Nueva composicion farmaceutica y el proceso para su preparacion.
DE10005017A1 (de) * 2000-02-04 2001-08-09 Cognis Deutschland Gmbh Duftstofftabletten
NZ528886A (en) * 2001-05-01 2005-04-29 Pfizer Prod Inc A dry process for manufacturing a low dose pharmaceutical composition having uniform drug distribution and potency
US7151432B2 (en) 2001-09-19 2006-12-19 Immersion Corporation Circuit and method for a switch matrix and switch sensing
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
TW200404550A (en) * 2002-07-08 2004-04-01 Sankyo Co Cepharospolin formulation for oral use
JP4526247B2 (ja) * 2002-07-08 2010-08-18 第一三共株式会社 経口用セファロスポリン製剤
PL1732605T3 (pl) 2004-03-29 2019-09-30 Wyeth Llc Multiwitaminowe i mineralne suplementy odżywcze
US8968768B2 (en) * 2004-03-29 2015-03-03 Wyeth Llc Phytosterol nutritional supplements
US9198862B2 (en) 2005-07-22 2015-12-01 Rubicon Research Private Limited Dispersible tablet composition
WO2007018192A1 (ja) 2005-08-10 2007-02-15 Shionogi & Co., Ltd. 口腔内崩壊錠剤
CN102579455B (zh) * 2012-03-19 2014-02-19 迪沙药业集团有限公司 一种稳定的头孢克洛咀嚼组合物
AU2016321659A1 (en) * 2015-09-14 2018-05-10 Merck Patent Gmbh Formulation having controlled, delayed active-ingredient release
CN113750066B (zh) * 2021-10-12 2022-12-02 上海金城素智药业有限公司 一种具有临床优势的头孢克洛制剂及其制备方法和应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2259646C2 (de) * 1972-12-06 1984-11-22 Hoechst Ag, 6230 Frankfurt Hochdosierte Tabletten von Cephalosporin-Derivaten sowie Verfahren zu ihrer Herstellung
YU36970B (en) 1973-02-23 1984-08-31 Lilly Co Eli Process for obtaining 7-(amino)-acylamido-3-halocephalosporins
US3925372A (en) 1973-02-23 1975-12-09 Lilly Co Eli Alpha-aminoacyl-3-halo cephalosporins
US4143129A (en) * 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
GB2066662B (en) * 1979-12-21 1984-02-15 Glaxo Group Ltd Cephalexin powder compositions containing silicon dioxide
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
EP0181966A1 (en) * 1984-11-13 1986-05-28 Gist-Brocades N.V. Compression-coated dispersible tablets
ES2061623T3 (es) * 1987-03-02 1994-12-16 Brocades Pharma Bv Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.
ATE72118T1 (de) * 1987-11-30 1992-02-15 Gist Brocades Nv Pharmazeutische zusammensetzung und verfahren zu ihrer herstellung.
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
GB9009473D0 (en) * 1990-04-27 1990-06-20 Beecham Group Plc Pharmaceutical formulation
FR2669221B1 (fr) * 1990-11-15 1993-01-15 Rhone Poulenc Sante Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique.
DE69013689T2 (de) * 1990-11-29 1995-03-02 Wei Ming Pharmaceutical Mfg Co Hilfsträger für direkte Verpressung.
SK282071B6 (sk) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Tableta dispergovateľná vo vode a spôsob jej prípravy
GB9109862D0 (en) * 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
IT1251999B (it) * 1991-11-11 1995-05-27 Opos Biochimica Srl Forma cristallina di un antibiotico cefalosporinico
CZ283428B6 (cs) * 1992-04-30 1998-04-15 Schering Corporation Stabilní hydratovaný suchý práškový cefalosporin vhodný pro orální aplikaci ve formě suspenze
US5503846A (en) * 1993-03-17 1996-04-02 Cima Labs, Inc. Base coated acid particles and effervescent formulation incorporating same
US5506248A (en) * 1993-08-02 1996-04-09 Bristol-Myers Squibb Company Pharmaceutical compositions having good dissolution properties
US5622719A (en) * 1993-09-10 1997-04-22 Fuisz Technologies Ltd. Process and apparatus for making rapidly dissolving dosage units and product therefrom
US5616344A (en) * 1994-06-14 1997-04-01 Fuisz Technologies Ltd. Apparatus and process for strengthening low density compression dosage units and product therefrom
US5895664A (en) * 1993-09-10 1999-04-20 Fuisz Technologies Ltd. Process for forming quickly dispersing comestible unit and product therefrom
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin

Also Published As

Publication number Publication date
PL181437B1 (pl) 2001-07-31
ES2079327B1 (es) 1996-08-01
PL309863A1 (en) 1996-06-24
HU9502160D0 (en) 1995-09-28
DE716852T1 (de) 1997-04-03
AU2509495A (en) 1996-06-20
NO953192L (no) 1996-06-14
PT716852E (pt) 2001-09-28
CO4410176A1 (es) 1997-01-09
JPH08208484A (ja) 1996-08-13
IL114642A (en) 1999-07-14
HK1012574A1 (en) 1999-08-06
NO309925B1 (no) 2001-04-23
CN1130506A (zh) 1996-09-11
EP1086690A3 (en) 2001-07-11
IL114642A0 (en) 1995-11-27
EP1086689A2 (en) 2001-03-28
DE69521275D1 (de) 2001-07-19
CZ199895A3 (en) 1996-07-17
TW492875B (en) 2002-07-01
RU2150276C1 (ru) 2000-06-10
YU60795A (sh) 1998-07-10
CA2158511A1 (en) 1996-06-14
HUT73792A (en) 1996-09-30
PE5196A1 (es) 1996-03-26
KR100350565B1 (ko) 2003-02-05
ES2091738T1 (es) 1996-11-16
BR9504573A (pt) 1997-02-25
TR199501165A1 (tr) 1996-10-21
DK0716852T3 (da) 2001-09-03
FI953887A (sv) 1996-06-14
EP0716852B1 (en) 2001-06-13
CN1136852C (zh) 2004-02-04
ZA956411B (en) 1996-03-11
DE69521275T2 (de) 2001-10-31
GR960300062T1 (en) 1996-11-30
KR960021026A (ko) 1996-07-18
ES2091738T3 (es) 2001-08-16
NO953192D0 (no) 1995-08-14
UA34479C2 (uk) 2001-03-15
SI0716852T1 (en) 2001-12-31
CZ287248B6 (en) 2000-10-11
EP1086690A2 (en) 2001-03-28
ES2079327A1 (es) 1996-01-01
GR3036503T3 (en) 2001-11-30
NZ272611A (en) 1997-08-22
EP1086689A3 (en) 2001-07-11
EP0716852A1 (en) 1996-06-19
MY114687A (en) 2002-12-31
ATE201984T1 (de) 2001-06-15
US5861141A (en) 1999-01-19
AU702585B2 (en) 1999-02-25

Similar Documents

Publication Publication Date Title
FI953887A0 (sv) Farmaceutiska kefaklorkompositioner
NO952863D0 (no) Fluoxetin-farmasöytiske sammensetninger
TW262461B (sv)
ATE232396T1 (de) Oxydiertes thymosin beta 4

Legal Events

Date Code Title Description
MA Patent expired